2009.03.26 Weekly Broadcast Email
The following updates were made the website for the week of March 23, 2009.
97202: A Randomized Double-Blind Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Cancer Treatment Related Fatigue in Breast Cancer Patients
The IRB approval letter for amendment 14 (closure) has been added to the website.
97405 (Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer)
Since the closure of the COLD-fX, is your site looking for a new study? Then consider enrolling patients in the Soy/Effexor trial.
Thank you to those sites who participated in the conference call on Monday. We appreciated hearing your ideas and feedback. Please contact the PIO if you have any further questions regarding the study.
Our goal is to have 125 more patients registered by June 1st. Click here to download the protocol documents, view slide show presentations, and more. Consider joining the Research Base in reaching its June 1st goal!